Silvani, Alessandro
Lambert, Isabelle
Heidbreder, Anna
Dauvilliers, Yves
Barateau, Lucie http://orcid.org/0000-0002-6620-5127
Article History
Accepted: 5 March 2023
First Online: 18 April 2023
Declarations
:
: Alessandro Silvani is an inventor in Italian patent application n. 102022000013894 related to a novel dual orexin receptor agonist and received speaker fees related to Idorsia and Bioprojet. Isabelle Lambert declares that she has no conflict of interest related to this article. Anna Heidbreder declares that she has no conflict of interest related to this article. Yves Dauvilliers declares that he has no conflict of interest related to this article; he received funds for seminars, board engagements, and travel to conferences by UCB Pharma, Jazz, Theranexus, Idorsia, Takeda, Avadel, and Bioprojet. Lucie Barateau declares that she has no conflict of interest related to this article; she received funds for traveling to conferences by UCB Pharma, Idorsia, and Bioprojet, and board engagements by Jazz, Takeda, Idorsia, and Bioprojet.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).